- News & Views
- Published:
Cancer nanotechnology
Subjects
STING-agonistic dual-stimuli-responsive nanoparticle achieves tumour-specific immunotherapy against metastatic cancers with minimal systemic toxicity.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
-
Hiam-Galvez, K. J., Allen, B. M. & Spitzer, M. H. Nat. Rev. Cancer 21, 345–359 (2021).
-
Demaria, O. et al. Nature 574, 45–56 (2019).
-
Esposito, M., Ganesan, S. & Kang, Y. Nat. Cancer 2, 258–270 (2021).
-
Irvine, D. J. & Dane, E. L. Nat. Rev. Immunol. 20, 321–334 (2020).
-
Guo, Z. et al. Mol. Pharm. 22, 7262–7284 (2025).
-
Stater, E. P., Sonay, A. Y., Hart, C. & Grimm, J. Nat. Nanotechnol. 16, 1180–1194 (2021).
-
Ye, S. et al. Nat. Nanotechnol. https://doi.org/10.1038/s41565-026-02130-3 (2026).
-
Edwards, S. C., Hoevenaar, W. H. M. & Coffelt, S. B. Br. J. Cancer 124, 37–48 (2021).
-
Wang, Z., Wang, Y., He, Z. & Liu, C. Adv. Sci. 12, e09890 (2025).
-
Huang, C. et al. Mater. Today Bio 23, 100839 (2023).
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Malhotra, M., Kulkarni, A. Logic‑gated nanomedicine activates STING to boost metastatic tumour immunotherapy. Nat. Nanotechnol. (2026). https://doi.org/10.1038/s41565-026-02131-2
-
Published:
-
Version of record:
-
DOI: https://doi.org/10.1038/s41565-026-02131-2
